Communicable Diseases Intelligence最新文献_第7页

Australian Meningococcal Surveillance Programme, 1 April to 30 June 2016. 澳大利亚脑膜炎球菌监测规划，2016年4月1日至6月30日。

IF 2.5

Communicable Diseases Intelligence Pub Date : 2016-09-30

Monica M Lahra, Rodnay P Enriquez

引用次数: 0

Australian Sentinel Practices Research Network, 1 January to 31 March 2016. 澳大利亚哨兵实践研究网络，2016年1月1日至3月31日。

IF 2.5

Communicable Diseases Intelligence Pub Date : 2016-06-30

Monique B-N Chilver, Daniel Blakeley, Nigel P Stocks

引用次数: 0

Q fever and contact with kangaroos in New South Wales. 在新南威尔士州感染Q热并与袋鼠接触。

IF 2.5

Communicable Diseases Intelligence Pub Date : 2016-06-30

James Flint, Craig B Dalton, Tony D Merritt, Stephen Graves, John K Ferguson, Maggi Osbourn, Keith Eastwood, David N Durrheim

引用次数: 0

Australian Paediatric Surveillance Unit annual report, 2014. 澳大利亚儿科监测单位年度报告，2014年。

IF 2.5

Communicable Diseases Intelligence Pub Date : 2016-06-30

Marie Deverell, Yvonne Zurynski, Elizabeth Elliott

引用次数: 0

Australian trachoma surveillance annual report, 2013. 2013年澳大利亚沙眼监测年度报告。

IF 2.5

Communicable Diseases Intelligence Pub Date : 2016-06-30

Carleigh S Cowling, Bette C Liu, Thomas L Snelling, James S Ward, John M Kaldor, David P Wilson

{"title":"Australian trachoma surveillance annual report, 2013.","authors":"Carleigh S Cowling, Bette C Liu, Thomas L Snelling, James S Ward, John M Kaldor, David P Wilson","doi":"","DOIUrl":"","url":null,"abstract":"Australia remains the only developed country to have endemic levels of trachoma (a prevalence of 5% or greater among children) in some regions. Endemic trachoma in Australia is found predominantly in remote and very remote Aboriginal communities. The Australian Government funds the National Trachoma Surveillance and Reporting Unit to collate, analyse and report trachoma prevalence data and document trachoma control strategies in Australia through an annual surveillance report. This report presents data collected in 2013. Data are collected from Aboriginal and Torres Strait Island communities designated at-risk for endemic trachoma within New South Wales, the Northern Territory, South Australia and Western Australia. The World Health Organization grading criteria were used to diagnose cases of trachoma in Aboriginal children, with jurisdictions focusing screening activities on the 5-9 years age group; but some children in the 1-4 and 10-14 years age groups were also screened. The prevalence of trachoma within a community was used to guide treatment strategies as a public health response. Aboriginal adults aged 40 years or over were screened for trichiasis. Screening coverage for the estimated population of children aged 5-9 years and adults aged 40 years or over in at-risk communities required to be screened in 2013 was 84% and 30%, respectively. There was a 4% prevalence of trachoma among children aged 5-9 years who were screened. Of communities screened, 50% were found to have no cases of active trachoma and 33% were found to have endemic levels of trachoma. Treatment was required in 75 at-risk communities screened. Treatment coverage for active cases and their contacts varied between jurisdictions from 79% to 100%. Trichiasis prevalence was 1% within the screened communities. ","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 2","pages":"E255-66"},"PeriodicalIF":2.5,"publicationDate":"2016-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34306474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Invasive pneumococcal disease surveillance, 1 January to 31 March 2016. 2016年1月1日至3月31日侵袭性肺炎球菌病监测。

IF 2.5

Communicable Diseases Intelligence Pub Date : 2016-06-30

Kate Pennington, Anna Glynn-Robinson, Cindy Toms

引用次数: 0

Australian Meningococcal Surveillance Programme annual report, 2014. 澳大利亚脑膜炎球菌监测规划年度报告，2014年。

IF 2.5

Communicable Diseases Intelligence Pub Date : 2016-06-30

Monica M Lahra, Rodney P Enriquez

{"title":"Australian Meningococcal Surveillance Programme annual report, 2014.","authors":"Monica M Lahra, Rodney P Enriquez","doi":"","DOIUrl":"","url":null,"abstract":"In 2014 there were 165 laboratory-confirmed cases of invasive meningococcal disease analysed by the Australian National Neisseria Network. This number was higher than the number reported in 2013, but was the second lowest reported since inception of the Australian Meningococcal Surveillance Programme in 1994. Probable and laboratory confirmed invasive meningococcal disease (IMD) are notifiable in Australia, and there were 170 IMD cases notified to the National Notifiable Diseases Surveillance System (NNDSS) in 2014. This was also higher than in 2013, but was the second lowest number of IMD cases reported to the NNDSS. The meningococcal serogroup was determined for 161/165 (98%) of laboratory confirmed IMD cases. Of these, 80.1% (129 cases) were serogroup B infections; 1.9% (3 cases) were serogroup C infections; 9.9% (16 cases) were serogroup W135; and 8.1% (13 cases) were serogroup Y. Primary and secondary disease peaks were observed in those aged 4 years or less, and in adolescents (15-19 years) respectively. Serogroup B cases predominated in all jurisdictions and age groups, except for those aged 65 years or over, where serogroups Y and W135 combined predominated. The overall proportion and number of IMD caused by serogroup B was higher than in 2013, but has decreased from previous years. The number of cases of IMD caused by serogroup C was the lowest reported to date. The number of IMD cases caused by serogroup Y was similar to previous years, but the number of IMD cases caused serogroup W135 was higher than in 2013. The proportion of IMD cases caused by serogroups Y and W135 has increased in recent years, whilst the overall number of cases of IMD has decreased. Molecular typing was able to be performed on 106 of the 165 IMD cases. In 2014, the most common porA genotypes circulating in Australia were P1.7-2,4 and P1.22,14. All IMD isolates tested were susceptible to ceftriaxone and ciprofloxacin. There were 2 isolates that were resistant to rifampicin. Decreased susceptibility to penicillin was observed in 88% of isolates. ","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 2","pages":"E221-8"},"PeriodicalIF":2.5,"publicationDate":"2016-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34753413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

An evaluation of the use of short message service during an avian influenza outbreak on a poultry farm in Young. 对杨氏家禽养殖场禽流感爆发期间短信服务使用情况的评估。

IF 2.5

Communicable Diseases Intelligence Pub Date : 2016-06-30

Lisa M Stephenson, Janice S Biggs, Vicky Sheppeard, Tracey L Oakman

{"title":"An evaluation of the use of short message service during an avian influenza outbreak on a poultry farm in Young.","authors":"Lisa M Stephenson, Janice S Biggs, Vicky Sheppeard, Tracey L Oakman","doi":"","DOIUrl":"","url":null,"abstract":"In 2013 an avian influenza outbreak occurred in a large poultry farm in Young (approximately 2 hours north-west of Canberra.) The responsible strain was H7N2, which is highly pathogenic and can affect humans. Daily surveillance was required for those individuals who were possibly exposed. This was conducted through the use of daily message through the short message service (SMS). A total of 55 people were identified as having had high risk exposure and requiring monitoring during the surveillance period from 16 to 25 October 2013. A SMS message was sent daily to each contact within 2 groups. (Group 1 were contacts who agreed to take Tamiflu prophylaxis, and Group 2 were contacts who were under surveillance but declined Tamiflu prophylaxis). The average daily response rate for SMS was 66% (median 75%) over a 9 day period. Of those who nominated to receive the daily SMS 98% confirmed they'd received the SMS and it reminded them to take their Tamiflu medication. The public health unit (PHU) team found the use of SMS to be less time consuming than conducting telephone follow-up interviews. The PHU team believed that the use of the technology decreased the likelihood of additional staff being required to assist in the outbreak. Utilising SMS was a new initiative for the PHU and staff found it overall easy to use. These findings confirm there can be significant benefits to using SMS during a large surveillance activity. The application of SMS during this outbreak was estimated at 2.5 times more cost effective that telephone follow-ups and would substantially reduce staffing costs further in the event of a very large outbreak. ","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 2","pages":"E195-201"},"PeriodicalIF":2.5,"publicationDate":"2016-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34753408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Creutzfeldt-Jakob disease surveillance in Australia: update to December 2014. 澳大利亚克雅氏病监测:更新至2014年12月

IF 2.5

Communicable Diseases Intelligence Pub Date : 2016-06-30

Genevieve M Klug, Alison Boyd, Shannon Sarros, Christiane Stehmann, Marion Simpson, Catriona McLean, Colin L Masters, Steven J Collins

引用次数: 0

Australian Group on Antimicrobial Resistance Australian Enterococcal Sepsis Outcome Programme annual report, 2014. 2014年澳大利亚肠球菌败血症结果规划年度报告。

IF 2.5

Communicable Diseases Intelligence Pub Date : 2016-06-30

Geoffrey W Coombs, Denise A Daley, Yung Thin Lee, Stanley Pang, Julie C Pearson, J Owen Robinson, Paul Dr Johnson, Despina Kotsanas, Jan M Bell, John D Turnidge

{"title":"Australian Group on Antimicrobial Resistance Australian Enterococcal Sepsis Outcome Programme annual report, 2014.","authors":"Geoffrey W Coombs, Denise A Daley, Yung Thin Lee, Stanley Pang, Julie C Pearson, J Owen Robinson, Paul Dr Johnson, Despina Kotsanas, Jan M Bell, John D Turnidge","doi":"","DOIUrl":"","url":null,"abstract":"From 1 January to 31 December 2014, 27 institutions around Australia participated in the Australian Enterococcal Sepsis Outcome Programme (AESOP). The aim of AESOP 2014 was to determine the proportion of enterococcal bacteraemia isolates in Australia that were antimicrobial resistant, and to characterise the molecular epidemiology of the Enterococcus faecium isolates. Of the 952 unique episodes of bacteraemia investigated, 94.4% were caused by either E. faecalis (54.9%) or E. faecium (39.9%). Ampicillin resistance was detected in 0.6% of E. faecalis and in 89.4% of E. faecium. Vancomycin non-susceptibility was reported in 0.2% and 46.1% of E. faecalis and E. faecium respectively. Overall 51.1% of E. faecium harboured vanA or vanB genes. For the vanA/B positive E. faecium isolates, 81.5% harboured vanB genes and 18.5% vanA genes. The percentage of E. faecium bacteraemia isolates resistant to vancomycin in Australia is significantly higher than that seen in most European countries. E. faecium consisted of 113 pulsed-field gel electrophoresis pulsotypes of which 68.9% of isolates were classified into 14 major pulsotypes containing 5 or more isolates. Multilocus sequence typing grouped the 14 major pulsotypes into clonal cluster 17, a major hospital-adapted polyclonal E. faecium cluster. The geographical distribution of the 4 predominant sequence types (ST203, ST796, ST555 and ST17) varied with only ST203 identified across most regions of Australia. Overall 74.7% of isolates belonging to the four predominant STs harboured vanA or vanB genes. In conclusion, the AESOP 2014 has shown enterococcal bacteraemias in Australia are frequently caused by polyclonal ampicillin-resistant high-level gentamicin resistant vanA or vanB E. faecium, which have limited treatment options. ","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 2","pages":"E236-43"},"PeriodicalIF":2.5,"publicationDate":"2016-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34306472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0